Related references
Note: Only part of the references are listed.Rate of major bleeding with ibrutinib versus bendamustine-rituximab in chronic lymphocytic leukemia: A population-based cohort study
Neil Dhopeshwarkar et al.
AMERICAN JOURNAL OF HEMATOLOGY (2022)
The risk of bleeding in patients receiving ibrutinib combined with novel direct oral anticoagulants
Michal Ariela Raz et al.
BRITISH JOURNAL OF HAEMATOLOGY (2020)
Incidence of and risk factors for major haemorrhage in patients treated with ibrutinib: An integrated analysis
Jennifer R. Brown et al.
BRITISH JOURNAL OF HAEMATOLOGY (2019)
Ibrutinib-Associated Atrial Fibrillation
Sarju Ganatra et al.
JACC-CLINICAL ELECTROPHYSIOLOGY (2018)
An automated database case definition for serious bleeding related to oral anticoagulant use
Andrew Cunningham et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2011)
Accuracy of coding for possible warfarin complications in hospital discharge abstracts
T. Arnason et al.
THROMBOSIS RESEARCH (2006)
Share Paper
